Bioavailability estimation by semisimultaneous drug administration: A Monte Carlo simulation study

[1]  Yasuaki Ogawa,et al.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  P. Collier,et al.  Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  L. Benet,et al.  An integrated approach to the pharmacokinetic analysis of drug absorption , 1974, Journal of pharmacokinetics and biopharmaceutics.

[4]  U. Bredberg,et al.  Estimation of Bioavailability on a Single Occasion After Semisimultaneous Drug Administration , 1989, Pharmaceutical Research.

[5]  A. Grahnén,et al.  Implications of intraindividual variability in bioavailability studies of furosemide , 2004, European Journal of Clinical Pharmacology.

[6]  Weiner Dl.  NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. , 1986 .

[7]  R. Wolen.  The Application of Stable Isotopes to Studies of Drug Bioavailability and Bioequivalence , 1986, Journal of clinical pharmacology.

[8]  M. Gibaldi,et al.  Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates. , 1985, Journal of pharmaceutical sciences.

[9]  J. Wagner,et al.  The Assessment of the Intrasubject Variability in Digoxin Absorption in Man from Two Oral Dosage Forms , 1981, Journal of clinical pharmacology.

[10]  S. Szefler,et al.  Intrasubject variation in sustained-release theophylline absorption. , 1981, The Journal of allergy and clinical immunology.

[11]  F. Koss,et al.  The use of stable isotopes to prove the saturable first-pass effect of methoxsalen. , 1980, Biomedical mass spectrometry.

[12]  K. C. Kwan,et al.  Bioavailability assessment under quasi- and nonsteady-state conditions III: Application. , 1976, Journal of Pharmacy and Science.

[13]  K. C. Kwan,et al.  Bioavailability assessment under quasi- and nonsteady-state conditions II: study designs. , 1976, Journal of Pharmacy and Science.

[14]  E. E. Mitchell,et al.  Advanced Continuous Simulation Language (ACSL) , 1976 .

[15]  A. Atkinson,et al.  Absolute bioavailability in man of N‐acetylprocainamide determined by a novel stable isotope method , 1975, Clinical pharmacology and therapeutics.

[16]  K. C. Kwan,et al.  Bioavailability assessment under quasi- and nonsteady-state conditions. I: theoretical considerations. , 1975, Journal of Pharmacy and Science.

[17]  K. C. Kwan,et al.  Novel method for bioavailability assessment. , 1973, Journal of pharmaceutical sciences.